Skip to main content
. 2023 Apr 30;5(3):fcad145. doi: 10.1093/braincomms/fcad145

Table 1.

Baseline characteristics of identified SE patients

All SE patients SE patients with an epilepsy diagnosis at baseline
Number of patients 2782 1585
Mean (SD│median) observation time in days 545.2 (456.1│514) 635.8 (442.6│631)
Mean (SD│median) age in years at the index date 64.3 (23.4│70.5) 62.3 (22.6│66)
Male/female gender 47.7%/52.3% 50.1%/49.9%
Mean (SD│median) CCI for the 12-month pre-index period 4.4 (3.5│4) 4.4 (3.6│4)
Etiologic factors
Stroke
n (%) acutea 212 (7.6%) 57 (3.6%)
n (%) remoteb 247 (8.9%) 156 (9.8%)
Progressive vascular leucoencephalopathy
n (%) acutea 0 0
n (%) remoteb 1 (0.1%) 0
Brain tumour
n (%) acutea 15 (0.5%) 6 (0.4%)
n (%) remoteb 17 (0.6%) 10 (0.6%)
Metabolic disorder
n (%) acutea 21 (0.8%) 10 (0.6%)
n (%) remoteb 103 (3.7%) 65 (4.1%)
Mental or behavioural disorders due to use of alcohol
n (%) acutea 18 (0.7%) 9 (0.6%)
n (%) remoteb 75 (2.7%) 52 (3.3%)
Injuries to the head
n (%) acutea 59 (2.1%) 18 (1.1%)
n (%) remoteb 113 (4.1%) 77 (4.9%)
Epilepsy-related hospitalization
n (%) in the 12-month baseline period 472 (17%) 472 (29.8%)
a

Acute: at index hospitalization or respective in-patient main diagnosis within 7 days before the index date. bRemote: respective in-patient main diagnosis within the 12-month baseline period but >7 days before index hospitalization.